Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Deciphera Pharmaceuticals Inc (NQ: DCPH )

25.36 -0.01 (-0.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,795,434
Open 25.40
Bid (Size) 25.31 (3)
Ask (Size) 26.00 (1)
Prev. Close 25.37
Today's Range 25.34 - 25.55
52wk Range 9.900 - 25.55
Shares Outstanding 58,041,410
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
DCPH Stock Earnings: Deciphera Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
DCPH stock results show that Deciphera Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PlayAGS, Incorporated (NYSE - AGS), HashiCorp Inc. (Nasdaq - HCP), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH), Territorial Bancorp, Inc. (Nasdaq - TBNK)
From Brodsky & Smith LLC
Via GlobeNewswire

Performance

YTD
+53.23%
+53.23%
1 Month
+62.46%
+62.46%
3 Month
+61.22%
+61.22%
6 Month
+120.33%
+120.33%
1 Year
+84.44%
+84.44%

More News

Read More
DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPH
From Kahn Swick & Foti, LLC
Via Business Wire
Deep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
Earnings Scheduled For February 6, 2024
Via Benzinga
Earnings Outlook For Deciphera Pharmaceuticals
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HashiCorp Inc. (Nasdaq - HCP), Heartland Financial, USA Inc. (Nasdaq - HTLF), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH), Territorial Bancorp, Inc. (Nasdaq -
From Brodsky & Smith LLC
Via GlobeNewswire
S&P 500 Edges Higher; ON Semiconductor Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?
Via Benzinga
Crude Oil Down Over 1%; Deciphera Pharmaceuticals Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Why Is Mullen Automotive (MULN) Stock Up 27% Today?
Via InvestorPlace
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Via Benzinga
Citi Just Raised Its Price Target on Shopify (SHOP) Stock
Via InvestorPlace
Why Is Deciphera Pharmaceuticals (DCPH) Stock Up 72% Today?
Via InvestorPlace
Dow Surges Over 100 Points; Domino's Pizza Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Deciphera Catapults 72% After Ono Pharmaceutical Agrees To Buy It For $2.4 Billion
Via Investor's Business Daily
DCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
From Deciphera Pharmaceuticals, Inc.
Via Business Wire
Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
From Deciphera Pharmaceuticals, Inc.
Via Business Wire
Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences
From Deciphera Pharmaceuticals, Inc.
Via Business Wire
Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results
From Deciphera Pharmaceuticals, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.